Second milestone payment from novo for exclusive license agreement of UBT251
Filed with HKEX · Stock code 3933 · · 1 page · English
Hong Kong Exchanges and Clearing Limited and The St Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no ock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance up
United Laboratories International Holdings Ltd. on 6ix
Earlier from United Laboratories International
- Notification Letter to Non-register Holder and Reply Form
- Notification Letter to Shareholder and Reply Form
- 2026 Interim report
- The group's product insulin degludec and liraglutide injection marketing registration application been accepted
- United Laboratories International Holdings: General mandates to issue securities and repurchase shares, re-election of directors and notice of annual general meeting
Later from United Laboratories International
All United Laboratories International news releasesFollow United Laboratories International into a list and get an email when it puts out news.
Follow United Laboratories International